Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases

M. Scudeletti, F. Puppo, L. Lanza, L. Mantovani, O. Bosco, A. Iudice, B. Imbimbo, F. Indiveri

Research output: Contribution to journalArticle

Abstract

Different glucocorticoid preparations modify the immune reaction in different ways. In this paper, the therapeutic efficacy of two glucocorticoids, deflazacort (DFZ) and prednisone (PDN), are discussed in relation to a group of 30 patients with systemic lupus erythematosus (n = 12) or rheumatoid arthritis (n = 18). The disease subgroups were divided into two arms, one of which was treated with DFZ and one with PDN in a double-blind protocol. The results of this study indicate that DFZ and PDN induced a clinical remission within 1 month which was maintained until the 6th month. Nevertheless, certain immunological modifications, including a significant reduction of the circulating T lymphocyte level and of the CD4/CD8 ratio, which was between 1 and 1,5 during the DFC treatment and between 1 and 2 during the PDN treatment, are more pronounced and more stable with DFZ than with PDN. Moreover, DFZ has a smaller effect on calcium and glucose metabolism than PDN since the serum glucose and calcium level of patients treated with PDN increased respectively from 90 up to 130 mg/dl and from 9,5 to 11,5 mg/dl whereas those of patients treated with DFC remained within the normal range. These findings indicate that DFZ may have advantages over PDN in the treatment of immune-mediated diseases.

Original languageEnglish
JournalEuropean Journal of Clinical Pharmacology
Volume45
Issue number1 Supplement
DOIs
Publication statusPublished - Jan 1993

Keywords

  • Deflazacort
  • glucocorticoid
  • immune disease
  • Prednisone

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases'. Together they form a unique fingerprint.

  • Cite this

    Scudeletti, M., Puppo, F., Lanza, L., Mantovani, L., Bosco, O., Iudice, A., Imbimbo, B., & Indiveri, F. (1993). Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases. European Journal of Clinical Pharmacology, 45(1 Supplement). https://doi.org/10.1007/BF01844201